Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Disease Activity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00350415
What this trial is testing

A Double Blind Study for the Treatment of Acute Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Warner Chilcott 772
Post-approval studies (Phase 4)Study completedNCT01408810
What this trial is testing

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Grupo de Estudo da Doença Inflamatória Intestinal 21
Not applicableUnknownNCT01783808
What this trial is testing

Intervention Study to Investigate Supplemental Oxygen in COPD

Who this might be right for
COPDPhysical ActivitySedentary
Uppsala University 144
Testing effectiveness (Phase 2)Looking for participantsNCT07427017
What this trial is testing

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

Who this might be right for
Ulcerative Colitis (UC)
Northwestern University 180
Post-approval studies (Phase 4)Looking for participantsNCT06180382
What this trial is testing

Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.

Who this might be right for
Crohn's Disease
Centre Hospitalier Universitaire de Saint Etienne 220
Not applicableStudy completedNCT03053713
What this trial is testing

The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of British Columbia 28
Large-scale testing (Phase 3)Study completedNCT00152490
What this trial is testing

Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

Who this might be right for
Crohn's Disease
UCB Pharma 604
Post-approval studies (Phase 4)UnknownNCT00295373
What this trial is testing

Exercise And Rosuvastatin Treatment: Is There an Anti-Inflammatory Synergy?

Who this might be right for
Nonfamilial HypercholesterolemiaPhysical Inactivity
Purdue University 48
Large-scale testing (Phase 3)Study completedNCT03915769
What this trial is testing

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Celgene 198
Large-scale testing (Phase 3)Study completedNCT00300118
What this trial is testing

Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD)

Who this might be right for
Crohn's Disease
Dr. Falk Pharma GmbH 311
Large-scale testing (Phase 3)Study completedNCT02914561
What this trial is testing

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Lakefront Biotherapeutics NV 1,372
Testing effectiveness (Phase 2)Looking for participantsNCT07265570
What this trial is testing

Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)

Who this might be right for
Ulcerative Colitis
InSilico Medicine Hong Kong Limited 80
Not applicableStudy completedNCT01270269
What this trial is testing

ACT-ICU Study: Activity and Cognitive Therapy in the Intensive Care Unit

Who this might be right for
Brain InjuriesDementiaMyopathies+1 more
Vanderbilt University 87
Large-scale testing (Phase 3)Study completedNCT02159053
What this trial is testing

16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis

Who this might be right for
Spondylitis, Ankylosing
Novartis Pharmaceuticals 350
Not applicableLooking for participantsNCT04046237
What this trial is testing

Impact of Treating Severe Periodontitis on Inflammatory Activity of Atheromatous Plaques in Patients With Acute Myocardial Infarction (AMI)

Who this might be right for
Acute Myocardial InfarctionSevere PeriodontitisCarotid Atherosclerosis
Assistance Publique - Hôpitaux de Paris 210
Testing effectiveness (Phase 2)Study completedNCT01647516
What this trial is testing

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Celgene 199
Testing effectiveness (Phase 2)Study completedNCT01714726
What this trial is testing

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Who this might be right for
Crohn's Disease
AstraZeneca 121
Not applicableStudy completedNCT03460847
What this trial is testing

Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa

Who this might be right for
Colitis, Ulcerative
Medical University of Graz 114
Not applicableStudy completedNCT02922881
What this trial is testing

Microbiota-targeted Diet for Pediatric UC

Who this might be right for
Ulcerative Colitis
Children's Hospital of Philadelphia 5
Testing effectiveness (Phase 2)Ended earlyNCT02895100
What this trial is testing

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Protagonist Therapeutics, Inc. 98
Next Page